Tru Independence LLC Repligen Corp Call Options Transaction History
Tru Independence LLC
- $309 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RGEN
# of Institutions
491Shares Held
57.6MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.01 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$954 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$679 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$226 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$224 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.42B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....